Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsHarvard Pilgrim step therapy Coverage & Prior Auth…
    Ask Trek AI about this page
    Currentharvard pilgrim health carePolicy N/A

    Step therapy and prior authorization requirements for select drugs (Antidepressants, Atypical Antipsychotics, Inhaled Corticosteroids, Interferons)

    Customize your policy alerts

    Sign up for all harvard pilgrim health care policy alerts

    Know when harvard pilgrim health care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Step therapy and prior authorization requirements for listed antidepressants, atypical antipsychotics, inhaled corticosteroids, and interferons for Tufts Health Plan Senior Care Options (HMO-SNP) members.

    Policy Summary
    Payerharvard pilgrim health care
    PolicyStep therapy and prior authorization requirements for select drugs (Antidepressants, Atypical Antipsychotics, Inhaled Corticosteroids, Interferons)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionProvide evidence of paid pharmacy claims or physician documentation showing required Step-1 (or Step-2 when allowed) medication fills within the previous 180 days to support coverage of Step-2 agents.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    180lookback period (days)
    Step-1covered without prior auth
    Step-2requires prior fill history
    2

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Rebif required fills

    Coverage Criteria — Step Therapy Rules

    Antidepressants

    Antidepressants — coverage rules

    Antidepressant coverage: Step-1 agents (bupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine, venlafaxine ER) are covered without prior authorization.
    Antidepressant Step-2: Emsam, Fetzima, and Exxua (including titration packs where applicable) are Step-2 and are covered only if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.>=1 fill in 180 days

    Providers must supply paid pharmacy claim or physician documentation to demonstrate prior fills.

    Atypical Antipsychotics

    Atypical antipsychotics — coverage rules

    Atypical antipsychotic coverage: Step-1 agents (aripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine, quetiapine, risperidone, ziprasidone) are covered without prior authorization.
    Atypical antipsychotic Step-2: Asenapine and Fanapt (including Fanapt titration packs) are Step-2 and will be covered if the member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.>=1 fill in 180 days

    Inhaled Corticosteroids

    Inhaled corticosteroids — coverage rules

    Inhaled corticosteroid coverage: QVAR is Step-1 and covered without prior authorization.
    Inhaled corticosteroid Step-2: Fluticasone products are Step-2 and will be covered if the member has filled for one or more Step-1 inhaled corticosteroid medications within the previous 180 days as evidenced by a paid claim or physician documentation.>=1 fill in 180 days

    Interferons

    Interferons — coverage rules

    Interferon coverage: Avonex, Betaseron, and Plegridy are Step-1 and covered without prior authorization.
    Interferon Step-2: Rebif and Rebif Rebidose (including titration packs) are Step-2 and will be covered if the member has filled for two or more Step-1 interferon medications within the previous 180 days as evidenced by a paid claim or physician documentation.>=2 fills in 180 days

    No additional exclusions are specified beyond the step therapy rules described for the listed drug classes. Coverage is determined by whether the member meets the Step-1 or Step-2 fill history requirements within the 180-day lookback period; if the required prior fills or documentation are not provided, Step-2 medications will be denied as described in the policy.

    Providers must document prior therapy with either a paid pharmacy claim or physician documentation showing the member filled the required Step-1 (or Step-2 where allowed) medication(s) within 180 days; for interferons (Rebif and Rebif Rebidose) the policy requires documentation of two or more Step-1 fills in that period.

    Step Therapy Placement by Drug Class

    Drug classStep-1 (coverage)Step-2 (coverage requirement)
    Antidepressants
    Bupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine, venlafaxine ER — covered without prior authorization.
    Emsam; Fetzima (including Fetzima Titration Pack); Exxua — Step-2. Covered only if member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.
    Drug classStep-1 (coverage)Step-2 (coverage requirement)
    Atypical antipsychotics
    Aripiprazole, lurasidone, olanzapine, olanzapine‑fluoxetine, quetiapine, risperidone, ziprasidone — covered without authorization.
    Asenapine; Fanapt (including Fanapt titration packs) — Step-2. Covered if member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.
    Drug classStep-1 (coverage)Step-2 (coverage requirement)
    Inhaled corticosteroids
    QVAR — Step-1; covered without authorization.
    Fluticasone products (e.g., Fluticasone Propionate HFA, Fluticasone Propionate Diskus) — Step-2. Covered if member has filled for one or more Step-1 inhaled corticosteroid medications within the previous 180 days as evidenced by a paid claim or physician documentation.
    Drug classStep-1 (coverage)Step-2 (coverage requirement)
    Interferons
    Avonex, Betaseron, Plegridy — Step-1; covered without prior authorization.
    Rebif; Rebif Rebidose (including Rebif/Rebidose titration packs) — Step-2. Covered only if member has filled for two or more Step-1 interferon medications within the previous 180 days as evidenced by a paid claim or physician documentation.

    Provider Requirements and Authorization Guidance

    Prior Authorization

    Antidepressant Step-2 prior fill required

    Emsam, Fetzima, and Exxua (including titration packs) are Step-2; for coverage, providers must document that the member filled a Step-1 or Step-2 antidepressant within the prior 180 days.

    • Required lookback period: 180 days
    • Acceptable evidence: paid pharmacy claim or physician documentation
    Prior Authorization

    Atypical antipsychotic Step-2 prior fill required

    Asenapine and Fanapt (and Fanapt titration packs) are Step-2; providers must show the member filled one or more Step-1 or Step-2 atypical antipsychotic medications within the previous 180 days for coverage.

    • Required lookback period: 180 days
    • Acceptable evidence: paid pharmacy claim or physician documentation

    Coding and Lookback Parameters

    inv-06: Prior fill lookback period required to satisfy Step-2 coverage
    Prior fill lookback period180 days (member must have filled required Step-1 or Step-2 medication within the previous 180 days)
    Evidence requiredPaid pharmacy claim or physician documentation to verify fills within 180 days
    Applies to classes listedAntidepressants, atypical antipsychotics, inhaled corticosteroids, and interferons
    inv-07: Required number of Step-1 interferon fills for Rebif
    Required number of Step-1 interferon fills for Rebif>= 2 fills within the previous 180 days (documentation must show two or more Step-1 medication fills)
    Evidence requiredPaid pharmacy claim or physician documentation to verify the two fills

    Background

    This document defines step therapy placement and prior authorization requirements for selected medications in four drug classes: antidepressants, atypical antipsychotics, inhaled corticosteroids, and interferons for Tufts Health Plan Senior Care Options (HMO‑SNP) members. It specifies which agents are designated Step-1 (covered without prior authorization) and which are Step-2 (require evidence of prior fills).

    The policy uses a 180-day lookback for prior medication fills to satisfy Step-2 requirements. For most Step-2 agents a single prior fill of a Step-1 (or Step-2 where permitted) within 180 days is required; for Rebif and Rebif Rebidose the policy requires documentation of two or more Step-1 interferon fills within the previous 180 days.

    Definitions

    inv-16: Definition of Step-1 — medications covered without prior authorization
    DefinitionMedications designated as first-line in their class that are covered without prior authorization.
    Examples (by class)Antidepressants (e.g., bupropion, citalopram, sertraline), Atypical antipsychotics (e.g., aripiprazole, quetiapine), Inhaled corticosteroids (QVAR), Interferons (Avonex, Betaseron, Plegridy)
    Authorization statusCovered without prior authorization when prescribed as indicated
    inv-17: Definition of Step-2 — medications requiring evidence of prior fills within the previous 180 days
    DefinitionMedications that require evidence of prior fills of Step-1 (or Step-2 where specified) medications within the previous 180 days to be covered.
    Required evidence

    Revision History

    Effective: July 1, 2026Policy effective dateLatest

    Step therapy and prior authorization requirements (180-day lookback; class-specific prior-fill counts) take effect for Tufts Health Plan Senior Care Options (HMO-SNP).

    Policy Summary
    Payerharvard pilgrim health care
    PolicyStep therapy and prior authorization requirements for select drugs (Antidepressants, Atypical Antipsychotics, Inhaled Corticosteroids, Interferons)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionProvide evidence of paid pharmacy claims or physician documentation showing required Step-1 (or Step-2 when allowed) medication fills within the previous 180 days to support coverage of Step-2 agents.
    SourceLink
    On This Page
    Coverage Criteria — Step Therapy RulesStep Therapy Placement by Drug ClassProvider Requirements and Authorization GuidanceCoding and Lookback ParametersBackgroundDefinitionsRevision History
    Prior Authorization

    Inhaled corticosteroid Step-2 prior fill required

    Fluticasone products are designated Step-2; providers must document that the member filled one or more Step-1 inhaled corticosteroid medications within the prior 180 days to obtain coverage.

    • Required lookback period: 180 days
    • Acceptable evidence: paid pharmacy claim or physician documentation
    Prior Authorization

    Interferon (Rebif) Step-2 two-fill requirement

    Rebif and Rebif Rebidose are Step-2 and require documentation that the member filled two or more Step-1 interferon medications within the previous 180 days for coverage.

    • Required number of Step-1 fills: ≥ 2 within 180 days
    • Acceptable evidence: paid pharmacy claim or physician documentation
    Step Therapy

    General step therapy requirement

    Step therapy applies across the listed classes: Step-1 agents are covered without prior authorization; Step-2 agents require prior fill history (one or two fills as specified) within the prior 180 days to be covered.

    • Step-1: covered without authorization
    • Step-2: requires evidence of prior fills within 180 days
    Documentation Required

    Evidence required to verify prior fills

    Providers must supply evidence of required prior medication fills by submitting paid pharmacy claims or physician documentation showing the member filled the Step-1 (or Step-2 when allowed) medication(s) within the previous 180 days; for Rebif, documentation must show two or more Step-1 fills.

    • Acceptable documentation: paid pharmacy claim or physician documentation
    • Lookback period: 180 days (two fills required for Rebif)
    Denial Risk

    Denial risk if required prior fills are not provided

    If there is no evidence of the required number of filled Step-1 (or Step-2 where specified) medications within the previous 180 days, coverage for the Step-2 medication will be denied.

    • Denial applies to listed Step-2 agents (examples: Emsam, Fetzima, Exxua; Asenapine, Fanapt; Fluticasone; Rebif) when prior-fill evidence is absent
    Applies to productsRebif and Rebif Rebidose (including titration packs)
    Paid pharmacy claim or physician documentation showing the required fills within 180 days
    Typical prior-fill thresholdOne prior fill in 180 days for most Step-2 agents; specific exceptions (e.g., interferons) require two fills